comprehensive -WSS

comprehensive

author：entertainment 2025-09-30 23:40:56 - browse：166

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Celebrate National Dole Whip Day for 3 days this week at Disney

focus

WSS

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Medical experts are missing from AI regulatory conversations

Man who had jail sentence commuted by Trump arrested again

States increasingly look to regulate hospital facility fees

Plane’s emergency slide plummets from sky, hits Chicago home

Wikipedia

comprehensive

focus

Medical leaders decry Supreme Court decision on affirmative action

Plane’s emergency slide plummets from sky, hits Chicago home

The high cost of giving birth even with insurance

The simple reason for the increase in autism diagnosis

In Memoriam: Notable people who died in 2023

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

Trump demands the U.S. pay no more for drugs than other countries … again

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

DIEP, the 'gold standard' of breast reconstruction, is under threat

New warning issued for rebooking air travel after delays, cancellations

leisure time

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Supreme Court rules employers must be more accommodating of religious observance

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

leisure time

focus

entertainment

explore